(Q33704125)

28 July 2017

1 reference

title

Investigation protocol: acromegaly and its investigation (English)

1 reference

28 July 2017

Duncan E

1

1 reference

28 July 2017

Wass JA

series ordinal

2

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

published in

Clinical Endocrinology

1 reference

28 July 2017

volume

50

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

285-293

1 reference

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Epidemiology of acromegaly in the Newcastle region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Growth Hormone Heterogeneity: Genes, Isohormones, Variants, and Binding Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Neuroendocrine regulation of growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Transsphenoidal surgery for acromegaly--long-term results in 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Sleep apnea in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Acromegaly. Recognition and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with sandostatin (SMS 201-995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Investigation of the criteria for assessing the outcome of treatment in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Production of “Sulphation Factor” by the Perfused Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Glucose and osmosensitive neurones of the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Hypothalamic neuronal hamartoma associated with pituitary growth hormone cell adenoma and acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Increased growth hormone pulse frequency in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Acromegaly, colonic polyps and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Determinants of clinical outcome and survival in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Acromegaly and gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Effects of synthetic thyrotropin-releasing hormone on plasma thyrotropin, growth hormone and insulin levels in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00615.X

10.1046/J.1365-2265.1999.00615.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference